ZOM - Zomedica Corp.
Close
0.1289
0.002 1.862%
Share volume: 2,083,438
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Surgical and Medical Instrument Manufacturing :
0.39%
PREVIOUS CLOSE
CHG
CHG%
$0.13
0.00
1.90%
Fundamental analysis
19%
Profitability
8%
Dept financing
2%
Liquidity
75%
Performance
20%
Performance
5 Days
-5.57%
1 Month
-13.43%
3 Months
-21.64%
6 Months
-5.50%
1 Year
-30.14%
2 Year
-47.47%
Key data
Stock price
$0.13
DAY RANGE
$0.13 - $0.13
52 WEEK RANGE
$0.12 - $0.23
52 WEEK CHANGE
-$0.32
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
Company detail
CEO: Larry C. Heaton
Region: US
Website: zomedica.com
Employees: 50
IPO year: -
Issue type: Common Stock
Market: NYSE American
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Region: US
Website: zomedica.com
Employees: 50
IPO year: -
Issue type: Common Stock
Market: NYSE American
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Zomedica Corp. focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats. PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals.
Recent news